IM
Immunovant, Inc.
IMVT·42227C102·UT·Common Stock·Healthcare - Biotechnology
IMVT (Immunovant, Inc.) is held by 0 institutional investors as of Q4 2019. Net institutional sentiment: Bearish.
0
Holders
$0
Total Value
0% (4)
Consensus
0 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Oct 9, 2026 · Activists none · Congress none
InsiderGMGloria MelanieSell $72KOct 7, 2026
InsiderSSStout Jay SSell $51KOct 7, 2026
InsiderVCVan Tuyl ChristopherSell $43KOct 7, 2026
Checking access…
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $8,000 | 0.0% | +57.78% | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | +57.78% | 0 | |
Exited | 0(-100.0%) | $500,000 | 0.0% | +61.33% | 0 | |
Exited | 0(-100.0%) | $1.3M | 0.0% | +57.78% | 0 |
IMIMVTImmunovant, Inc.
Continue exploring
Other Healthcare stocks held by institutions
UNHUNITEDHEALTH GROUP INC417 holders · $300.5B
LLYELI LILLY & CO416 holders · $881.6B
TMOTHERMO FISHER SCIENTIFIC INC401 holders · $151.5B
JNJJOHNSON & JOHNSON398 holders · $415.6B
DHRDANAHER CORP DEL395 holders · $98.9B
ISRGINTUITIVE SURGICAL INC394 holders · $111.8B
MRKMERCK & CO INC391 holders · $230.3B
ABBVABBVIE INC386 holders · $303.9B
BSXBOSTON SCIENTIFIC CORP386 holders · $52.4B
ABTABBOTT LABORATORIES383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer